Samsung Biologics unveils $920 million manufacturing deals for Pfizer

SEOUL (Reuters) – South Korea’s Samsung Biologics announced on Tuesday two deals with Pfizer worth around a combined 1.2 trillion won ($921.38 million) to manufacture products for the U.S. pharmaceutical giant. The latest deals will see the biotech division of the Samsung Group produce biosimilar products ranging from oncology and inflammation to immunotherapy in the…

Read More

US manufacturing slump deepens, factory gate price pressures subdued

By Lucia Mutikani WASHINGTON (Reuters) – U.S. manufacturing slumped further in June, reaching levels last seen when the nation was reeling from the initial wave of the COVID-19 pandemic, but price pressures at the factory gate continued to deflate, a silver lining for the economy. Shrinking activity left factories resorting to layoffs, the survey from…

Read More

China to restrict exports of chipmaking materials as US mulls new curbs

BEIJING (Reuters) – China will control exports of some metals widely used in the semiconductor industry, its commerce ministry announced on Monday, the latest salvo in an escalating war over access to high-tech microchips between Beijing and the United States. The controls, which China said were aimed at protecting national security and interests, will require…

Read More

Trump-tied SPAC reaches agreement with SEC staff over merger

(Reuters) – A blank-check firm, which was set to merge with former U.S. President Donald Trump’s media company and under regulatory investigation, has reached an agreement with the staff of the Securities and Exchange Commission, a filing showed on Monday. The special purpose acquisition company (SPAC), Digital World Acquisition Corp, said in the filing that…

Read More

What would Japanese intervention to boost the weak yen look like?

By Leika Kihara TOKYO (Reuters) -Japanese authorities are facing renewed pressure to combat a continued yen fall driven by market expectations that the Bank of Japan will keep interest rates ultra-low, even as other central banks tighten monetary policy to curb inflation. Aside from verbal intervention, Japan’s government has several options to stem what it…

Read More

Musk’s Twitter rate limits could undermine new CEO, ad experts say

By Jody Godoy (Reuters) -Elon Musk’s move to temporarily cap how many posts Twitter users can read on the social media site could undermine efforts by new CEO Linda Yaccarino to attract advertisers, marketing industry professionals said. Musk announced Saturday that Twitter would limit how many tweets per day various accounts can read, to discourage “extreme…

Read More